Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease

Bone Marrow Transplantation volume 30, pages 539–541 (2002)Cite this article

Abstract

This report concerns a case of long-lasting pure red cell aplasia (PRCA) with a duration of 178 days after major ABO-incompatible allogeneic peripheral blood stem cell transplantation (PBSCT). The patient needed red blood cell transfusion every week from day 54 following PBSCT. He showed no evidence of GVHD and the dose of cyclosporin A (CsA) was reduced rapidly from day 123, followed by the development of chronic GVHD around day 145. The patient no longer needed transfusions from day 167, the reticulocyte count began to increase on day 179, and antidonor isohemagglutinin titers became undetectable. Chronic GVHD induced by tapering of CsA thus appeared to be related to improvement in PRCA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma New Engl J Med 1989 320: 197 204

    Article  CAS  PubMed  Google Scholar 

  2. Hershko C, Gale RP, Ho W, Fitchen J . ABH antigens and bone marrow transplantation Br J Haematol 1980 44: 65 73

    Article  CAS  PubMed  Google Scholar 

  3. Sniecinski IJ, Oien L, Petz LD, Blume KG . Immunohematologic consequences of major ABO-mismatched bone marrow transplantation Transplant 1988 45: 530 534

    Article  CAS  Google Scholar 

  4. Gmür JP, Burger J, Schaffner A et al. Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation Blood 1990 75: 290 295

    PubMed  Google Scholar 

  5. Worel N, Greinix HT, Schneider B et al. Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems Transplantation 2000 40: 543 550

    CAS  Google Scholar 

  6. Takamoto S, Yazawa Y, Yamamoto E et al. ABO incompatible bone marrow transplantation – analysis of 28 cases Vox Sang 1996 70: (Suppl. 2) 139 (Abstr. 3/4B-06 P)

    Google Scholar 

  7. Ohta S, Yokoyama H, Ise T et al. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation Intern Med 1997 36: 487 491

    Article  CAS  PubMed  Google Scholar 

  8. Heyll A, Aul C, Runde V et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin Blood 1991 77: 906 (letter)

    CAS  PubMed  Google Scholar 

  9. Furuya H, Wakayama T, Tanaka J et al. Treatment with bolus methylprednisolone for pure red cell aplasia after ABO incompatible bone marrow transplantation in a patient with chronic myelocytic leukemia Jpn J Clin Hematol 1995 36: 1279 1283

    CAS  Google Scholar 

  10. Labar B, Bogdanic V, Nemet D et al. Antilymphocyte globulin for treatment of pure red cell aplasia after major ABO incompatible marrow transplant Bone Marrow Transplant 1992 10: 471 472

    CAS  PubMed  Google Scholar 

  11. Ohashi K, Akiyama H, Takamoto S et al. Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation resistant to erythropoietin Bone Marrow Transplant 1994 13: 335 336

    CAS  PubMed  Google Scholar 

  12. Yang MH, Hsu HC . Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review Ann Hematol 2001 80: 299 301

    Article  CAS  PubMed  Google Scholar 

  13. Mielcarek M, Leisenring W, Torok-Storb B, Storb R . Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect Blood 2000 96: 1150 1156

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology and Immunology, Ishikawa Prefectural Central Hospital, Kanazawa, Japan

    M Yamaguchi, K Sakai, R Murata & M Ueda

Authors
  1. M Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K Sakai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R Murata
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamaguchi, M., Sakai, K., Murata, R. et al. Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease. Bone Marrow Transplant 30, 539–541 (2002). https://doi.org/10.1038/sj.bmt.1703699

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703699

Keywords

This article is cited by

Search

Advanced search

Quick links